ANAB
ANAPTYSBIO, INC
+0.59 (+1.09%)54.90USD102K成交股數1.6B市值–本益比(近四季)6.9股價營收比-8.0%營收年增(近四季)2026-09-21下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 25.6M-8% | 108M+261% | 76.3M+596% | 22.3M+210% | 27.8M+208% | 30.0M+805% | 11.0M+217% | 7.2M+422% | 9.0M | 3.3M | 3.5M | 1.4M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 34.0M | 25.6M | 31.4M | 37.8M | 41.2M | 42.2M | 42.0M | 37.0M | 33.5M | 30.9M | 32.9M | 35.0M |
| 銷售管理費用 | 26.2M | 15.8M | 10.2M | 10.6M | 14.1M | 10.6M | 9.3M | 12.3M | 10.3M | 10.2M | 10.7M | 10.8M |
| 營業利益 | −34.6M+26% | 66.9M-394% | 34.7M-186% | −26.2M-38% | −27.5M-35% | −22.8M-40% | −40.3M+0% | −42.2M-5% | −42.1M | −37.7M | −40.1M | −44.4M |
| 營業利益率 | -135.5% | 61.8% | 45.5% | -117.5% | -99.2% | -75.8% | -367.5% | -587.8% | -467.9% | -1,137.2% | -1,160.2% | -3,231.5% |
| 稅後淨利 | −52.9M+34% | 49.6M-251% | 15.1M-132% | −38.6M-12% | −39.3M-7% | −32.9M-12% | −46.7M+17% | −43.9M-1% | −42.2M | −37.3M | −39.8M | −44.3M |
| 淨利率 | -206.9% | 45.8% | 19.8% | -173.5% | -141.6% | -109.4% | -425.3% | -612.0% | -468.8% | -1,124.4% | -1,151.6% | -3,220.9% |
| 稀釋 EPS | -1.84+44% | 1.64-244% | 0.52-130% | -1.34-18% | -1.28-19% | -1.14-19% | -1.71+14% | -1.64+4% | -1.59 | -1.41 | -1.50 | -1.58 |
| 稀釋股數 | 28.7M | 28.8M | 29.0M | 28.8M | 30.6M | 28.9M | 27.4M | 26.8M | 26.9M | 26.5M | 26.6M | 28.0M |
資產負債表 期末餘額
| 科目 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 248M | 238M | 110M | 44.3M | 98.6M | 192M | 71.8M | 53.7M | 36.0M | 26.3M | 35.2M | 94.6M |
| 應收帳款 | 25.7M | 33.9M | 75.7M | 21.4M | 17.9M | 12.2M | 9.0M | 7.1M | 6.9M | 3.3M | 3.2M | 1.5M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 330M | 364M | 353M | 335M | 422M | 493M | 427M | 406M | 452M | 487M | 517M | 552M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | 12.7M | 37.2M | −29.4M | −44.7M | 34.0M | 84.4M | 9.9M | 47.8M | 88.1M | 120M | 148M | 191M |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | −25.9M+142% | – | – | – | −10.7M | – | – | −37.3M+52% | – | – | – | −24.6M |
| 資本支出 | 17K | – | – | – | 35K | – | – | 27K | – | – | – | 175K |
| 自由現金流 | −25.9M+142% | – | – | – | −10.7M | – | – | −37.3M+51% | – | – | – | −24.7M |
| 折舊攤銷 | 130K | – | – | – | 146K | – | – | 163K | – | – | – | 166K |
| 買回庫藏股 | 0.00 | – | – | – | 4.4M | – | – | 0.00 | – | – | – | 37.5M |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | -101.5% | – | – | – | -38.7% | – | – | -519.3% | – | – | – | -1,800.8% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 235M
| Royalty Management Company | 235M | 100.0% | +157.0% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 235M | +157.0% | −13.2M | -5.6% | -0.46 | 19.6M |
| FY2024 | 91.3M | +432.0% | −145M | -159.1% | -5.12 | −136M |
| FY2023 | 17.2M | +66.8% | −164M | -953.7% | -6.08 | −122M |
| FY2022 | 10.3M | -83.7% | −129M | -1,251.3% | -4.57 | −74.0M |
| FY2021 | 63.2M | -15.8% | −57.8M | -91.5% | -2.11 | −47.3M |
| FY2020 | 75.0M | +837.5% | −19.9M | -26.6% | -0.73 | −14.7M |
| FY2019 | 8.0M | +60.0% | −97.3M | -1,216.7% | -3.60 | −70.3M |
| FY2018 | 5.0M | – | −61.7M | -1,233.1% | -2.50 | −49.6M |